The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study.
about
Real-World Effectiveness and Safety of a Live-Attenuated Herpes Zoster Vaccine: A Comprehensive ReviewRisk of Shingles in Adults with Primary Sjogren's Syndrome and Treatments: A Nationwide Population-Based Cohort StudyVaccinations for rheumatoid arthritis.2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.Herpes zoster and tofacitinib therapy in patients with rheumatoid arthritis.Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.The risk of herpes zoster in the anti-TNF-α era: a case report and review of the literature.Incidence and time trends of herpes zoster in rheumatoid arthritis: a population-based cohort studyAssociation between vaccination for herpes zoster and risk of herpes zoster infection among older patients with selected immune-mediated diseases.A Multifaceted Intervention to Improve Influenza, Pneumococcal, and Herpes Zoster Vaccination among Patients with Rheumatoid Arthritis.Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zosterIncreased risk of herpes zoster among 108 604 patients with inflammatory bowel disease.Immunogenicity and safety of different schedules of 2-dose varicella vaccination in China.Shingles (herpes zoster) vaccine (zostavax(®)): a review of its use in the prevention of herpes zoster and postherpetic neuralgia in adults aged ≥50 years.Opportunistic infections due to inflammatory bowel disease therapy.Vaccinating the inflammatory bowel disease patient.Vaccination of patients with autoimmune inflammatory rheumatic diseases.Immunizations in Pediatric and Adult Patients with Inflammatory Bowel Disease: A Practical Case-based Approach.Live attenuated herpes zoster vaccine for HIV-infected adults.Disseminated Varicella Zoster Virus Infection with Encephalitis in a UC Patient Receiving Infliximab.Safety of herpes zoster vaccination among inflammatory bowel disease patients being treated with anti-TNF medications.Shingles (Herpes Zoster) Vaccine (Zostavax(®)): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia.Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster.Management and Prevention of Herpes Zoster in the Immunocompromised Inflammatory Bowel Disease Patient: A Clinical Quandary.Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases.Editorial: Herpes Zoster: Fear the Infection, Value the Solution.Live viral vaccines in immunocompromised patientsA novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid ArthritisEfficacy, effectiveness, and safety of herpes zoster vaccines in adults aged 50 and older: systematic review and network meta-analysis
P2860
Q26748712-F2383E72-A842-4859-8E15-DD8746C9C5A6Q28547474-1C0E4F68-5AB7-46A5-9297-3C19303B0A92Q34424563-0B7D925B-6FE9-43A9-AB65-DE951DA659AEQ34500921-5DD1928C-DE0A-4AE3-A5DC-B2ED1F7F814EQ34851473-E146E97A-DF61-4560-B498-B2FD2FAC5E2BQ36679750-459D376D-997B-42F4-BF5D-C0143CD6A594Q36755236-5BFBE3D5-9AE8-4C54-8843-E6CEC020DEE5Q36906351-75454EFD-FD67-4D80-9F91-994CB49BF009Q36932760-4AB58104-551F-4BD1-8879-4F3765E4EC26Q36963507-A4F05C6D-75B8-40A4-BFC6-7F6AB36379CFQ37171211-C9D248C4-D7A9-4A6D-8E16-DCB296730322Q37456737-A16489DE-541E-4FD7-98F9-DE780EB5AB46Q37560864-70E4F635-A2D4-44FE-BA45-C03D01313961Q38120494-07555EE0-DB5C-4742-8694-77D588565368Q38139812-27DAEE90-B0C4-420C-ADB5-5939A9441BDFQ38243693-DF7E3FAD-74D8-4A54-853A-5372EFE2283EQ38285275-60093C12-1284-45AE-ADF4-7D1A60BAC1CDQ38475865-2F81D89A-223C-48C7-8EC4-D474E487DC52Q38575356-2322B4F2-2155-40AE-A901-F5A99C6D90C2Q38618046-DC406527-EC43-4623-8C88-C0245910A441Q38626287-5EACAB03-AF64-4271-A999-4CF06A591F92Q38836789-9E9AC48C-022D-4ACB-98DB-8B5F112B3F12Q38837769-EA51BA58-914B-47CD-AEFE-C7D24261C249Q38947199-A814A573-BC56-4713-BD41-94CD59D78940Q42187898-B9C982F6-667C-4F5B-94D8-2C334DDE41BBQ54362728-CCA52B59-EDFA-4944-B935-48793922EB82Q56765765-439BFCF5-2439-4008-9849-A72EA9EE7DA9Q56888201-D543E9A3-BAD5-45B2-BDE1-718375CAFF33Q57245378-9191DED0-88A4-4EAC-9EE4-E1E301E30093Q58553251-01CE6DE2-C67C-4C90-964B-A538230A5C2B
P2860
The use, safety, and effectiveness of herpes zoster vaccination in individuals with inflammatory and autoimmune diseases: a longitudinal observational study.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The use, safety, and effective ...... gitudinal observational study.
@ast
The use, safety, and effective ...... gitudinal observational study.
@en
type
label
The use, safety, and effective ...... gitudinal observational study.
@ast
The use, safety, and effective ...... gitudinal observational study.
@en
prefLabel
The use, safety, and effective ...... gitudinal observational study.
@ast
The use, safety, and effective ...... gitudinal observational study.
@en
P2093
P2860
P356
P1476
The use, safety, and effective ...... gitudinal observational study.
@en
P2093
Claire Spettell
Elizabeth Delzell
Fenglong Xie
Jeffrey R Curtis
Joaquim Fernandes
John W Baddley
Kevin Winthrop
Raechele M McMahan
P2860
P2888
P356
10.1186/AR3497
P577
2011-10-24T00:00:00Z
P5875
P6179
1000041927